Symbol="VKTX"
AssetType="Common Stock"
Name="Viking Therapeutics Inc"
Description="Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California."
CIK="1607678"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="12340 EL CAMINO REAL, SUITE 250, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1396753000"
EBITDA="None"
PERatio="None"
PEGRatio="-0.03"
BookValue="1.857"
DividendPerShare="0"
DividendYield="0"
EPS="-0.94"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.27"
ReturnOnEquityTTM="-0.457"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.94"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="33.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.865"
EVToRevenue="-"
EVToEBITDA="-2.068"
Beta="0.555"
num_52WeekHigh="25.72"
num_52WeekLow="2.535"
num_50DayMovingAverage="18.94"
num_200DayMovingAverage="12.52"
SharesOutstanding="99839000"
DividendDate="None"
ExDividendDate="None"
symbol="VKTX"
open="14.47"
high="14.47"
low="13.81"
price="14.16"
volume="1452166.00"
latest_trading_day="2023-08-01"
previous_close="14.50"
change="-0.34"
change_percent="-2.3448%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="25"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="75"
Volume_recent_avg="4165566"
Change_recent_avg="-0.05"
Delta_recent_avg="1.22"
Variance_recent_avg="0.61"
Change_ratio_recent_avg="-0.43"
RSI_change="FALSE"
ADX_change="TRUE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="75"
Aroon_momentum_negative="25"
image_negative_thumbnail_id_1="1131"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0164.jpeg"
image_negative_thumbnail_id_2="1162"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0196.jpeg"
image_neutral_thumbnail_id_1="592"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_neutral_thumbnail_id_2="594"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0005.jpeg"
image_positive_thumbnail_id_1="628"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0080.jpeg"
image_positive_thumbnail_id_2="692"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0016.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
